Confocal microscopy aids surgical removal of tumors from eyelid

December 27, 2016

(HealthDay)—Imaging using fluorescence confocal microscopy (FCM) analysis in the reflectance mode and with an "en face" scanning can control tumor margins of eyelid basal cell carcinoma (BCC) to optimize surgical management, according to a study published online Dec. 19 in Clinical & Experimental Ophthalmology.

Marine Espinasse, M.D., from University Hospital of St-Etienne in France, and colleagues evaluated the sensitivity and specificity of FCM for the presence of tumor-free margins in 41 patients undergoing excision of BCC of the eyelid. Histopathogical examination was later performed in order to compare the results of FCM in the reflectance mode and with a horizontal ("en face") scanning.

The researchers found that FCM results were consistent with histopathology in all cases. Tumor-free margins were seen in 40 out of 42 samples, yielding both a sensitivity and specificity for FCM of 100 percent.

"This procedure has the advantage on FCM performed in the fluorescent mode of not needing any contrast agent to examine the samples," the authors write.

Explore further: Reflectance confocal microscopy best IDs melanoma on head, neck

More information: Full Text (subscription or payment may be required)

Related Stories

Reflectance confocal microscopy best IDs melanoma on head, neck

September 5, 2016
(HealthDay)—Reflectance confocal microscopy (RCM) best identifies skin cancer lesions on the head and neck, and RCM morphologic patterns differ for distinct melanomas, according to two studies published online Aug. 31 in ...

CSF RT-QuIC has high diagnostic specificity, sensitivity for prions

December 3, 2016
(HealthDay)—Cerebrospinal fluid (CSF) real-time quaking-induced conversion (RT-QuIC) has high diagnostic specificity and sensitivity for prion diseases, according to a study published online Nov. 28 in the Annals of Neurology.

Glowing tumors help Penn surgeons cut out brain cancer with precision

November 16, 2016
An experimental cancer imaging tool that makes tumors glow brightly during surgery has shown promise again in a new Penn Medicine clinical study, this time in patients with brain cancer. The fluorescent dye technique, originally ...

Excision margins don't impact melanoma recurrence, survival

April 12, 2016
(HealthDay)—Wider excision margins in thick cutaneous melanoma cases do not improve locoregional recurrence or melanoma-specific survival (MSS), according to research published online March 25 in Head & Neck.

New research method to identify brain tumors could enhance neurosurgery

January 10, 2013
(Medical Xpress)—The use of a new brain tumor-targeting contrast agent that differentiates between normal and cancer cells in conjunction with a high-powered microscopy system could potentially lead to a method of more ...

Dual-modality DRS-FS discerns tumor from surrounding tissue

September 8, 2015
(HealthDay)—Dual-modality diffuse reflectance spectroscopy-fluorescence spectroscopy (DRS-FS) can differentiate tumor tissue from surrounding tissue in patients undergoing colorectal cancer resection, according to a study ...

Recommended for you

Research reveals da Vinci's genius may have been partly due to eye condition

October 19, 2018
Leonardo da Vinci may have had an eye condition that gave him an unusual ability to recreate three-dimensional shapes in his sculptures and paintings, according to new research.

Eating leafy greens could help prevent macular degeneration

October 19, 2018
A new study has shown that eating vegetable nitrates, found mainly in green leafy vegetables and beetroot, could help reduce your risk of developing early-stage age-related macular degeneration (AMD).

Widespread errors in 'proofreading' cause inherited blindness

October 12, 2018
Mistakes in "proofreading" the genetic code of retinal cells is the cause of a form of inherited blindness, retinitis pigmentosa (RP) caused by mutations in splicing factors.

Gene therapy breakthrough in treating rare form of blindness

October 9, 2018
Positive results of the world's first gene therapy trial for a genetic cause of blindness known as choroideremia have been reported in Nature Medicine.

Gene changes driving myopia reveal new focus for drug development

October 9, 2018
Myopia (nearsightedness) and hyperopia (farsightedness) develop through different molecular pathways, according to a new study publishing October 9 in the open-access journal PLOS Biology by Andrei Tkatchenko of Columbia ...

Dynamin-binding protein linked to congenital cataracts

October 4, 2018
Cataracts, a condition in which the eyes' natural lenses get clouded, are the most common cause of vision loss in older people and can be corrected by routine surgery. But congenital cataracts, which occur in infants and ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.